Vyne Therapeutics Stock Price on December 23, 2024
| VYNE Stock | USD 2.97 0.40 15.56% |
Below is the normalized historical share price chart for Vyne Therapeutics extending back to January 25, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vyne Therapeutics stands at 2.97, as last reported on the 26th of December, with the highest price reaching 3.07 and the lowest price hitting 2.53 during the day.
If you're considering investing in Vyne Stock, it is important to understand the factors that can impact its price. Vyne Therapeutics appears to be moderately volatile, given 3 months investment horizon. Vyne Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18% return per unit of risk over the last 3 months. By inspecting Vyne Therapeutics' technical indicators, you can evaluate if the expected return of 0.88% is justified by implied risk. Please review Vyne Therapeutics' Semi Deviation of 3.16, coefficient of variation of 584.91, and Risk Adjusted Performance of 0.1451 to confirm if our risk estimates are consistent with your expectations.
At present, Vyne Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 819 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 82 M. . At present, Vyne Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.28, whereas Price Earnings Ratio is forecasted to decline to (0.88). Vyne Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of January 2018 | 200 Day MA 2.2279 | 50 Day MA 2.1957 | Beta 1.354 |
Vyne |
Sharpe Ratio = 0.1771
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VYNE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.97 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.88 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Vyne Therapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vyne Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.6895 | Enterprise Value Ebitda 1.8403 | Price Sales 88.8675 | Shares Float 10.1 M | Wall Street Target Price 5.58 |
Vyne Therapeutics Main Headline on 23rd of December 2024
VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Dat... by gurufocus.com
Promising results support VYN202s potential as a novel, once-daily oral treatment for a broad range of immune-mediated disordersConsistent with Phase 1a SAD re
Vyne Therapeutics Valuation on December 23, 2024
It is possible to determine the worth of Vyne Therapeutics on a given historical date. On December 23, 2024 Vyne was worth 2.6 at the beginning of the trading date compared to the closed value of 2.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vyne Therapeutics stock. Still, in general, we apply an absolute valuation method to find Vyne Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vyne Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vyne Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.36 | 2.55 | 2.36 | 2.50 | 34,720 | |
12/23/2024 | 2.60 | 2.80 | 2.50 | 2.57 | 249,100 |
| 2.53 | 3.07 | 2.53 | 2.97 | 179,016 |
| Backtest Vyne Therapeutics | | | Vyne Therapeutics History | | | Vyne Therapeutics Valuation | Previous | Next |
Vyne Therapeutics Trading Date Momentum on December 23, 2024
| On December 24 2024 Vyne Therapeutics was traded for 2.97 at the closing time. The top price for the day was 3.07 and the lowest listed price was 2.53 . The trading volume for the day was 179 K. The trading history from December 24, 2024 was a factor to the next trading day price growth. The trading price change against the next closing price was 15.56% . The trading price change against the current closing price is 0.00% . |
Vyne Therapeutics Fundamentals Correlations and Trends
By evaluating Vyne Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vyne Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vyne financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vyne Therapeutics Stock history
Vyne Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vyne is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vyne Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vyne Therapeutics stock prices may prove useful in developing a viable investing in Vyne Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.3 M | 10.8 M | |
| Net Loss | -20.9 M | -21.9 M |
Vyne Therapeutics Quarterly Net Working Capital |
|
Vyne Therapeutics Stock Technical Analysis
Vyne Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vyne Therapeutics Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Vyne Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vyne Therapeutics December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Vyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Vyne Therapeutics stock market strength indicators, traders can identify Vyne Therapeutics entry and exit signals to maximize returns
Vyne Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vyne Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vyne Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vyne to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1451 | |||
| Jensen Alpha | 0.7918 | |||
| Total Risk Alpha | 0.6114 | |||
| Sortino Ratio | 0.2058 | |||
| Treynor Ratio | 0.9158 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Vyne Stock analysis
When running Vyne Therapeutics' price analysis, check to measure Vyne Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vyne Therapeutics is operating at the current time. Most of Vyne Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vyne Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vyne Therapeutics' price. Additionally, you may evaluate how the addition of Vyne Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |